AG Letitia James is yet again aiming to advance her political career at New Yorkers’ expense — by demanding hospitals violate ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

A fifth-grader in Texas was caught with a small bag of cocaine at school. They were then arrested and transported to a juvenile detention center. Recently, a student at Jefferson Elementary School in ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...